Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Other Accumulated Expenses (2016 - 2025)

BioRestorative Therapies (BRTX) has disclosed Other Accumulated Expenses for 10 consecutive years, with $607470.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Accumulated Expenses changed N/A year-over-year to $607470.0, compared with a TTM value of $607470.0 through Sep 2025, changed N/A, and an annual FY2024 reading of $744485.0, changed N/A over the prior year.
  • Other Accumulated Expenses was $607470.0 for Q3 2025 at BioRestorative Therapies, up from $480925.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $744485.0 in Q4 2024 and bottomed at $277610.0 in Q1 2025.